巧办法 发表于 2025-3-28 18:20:36
Neus Ferrer-Miralles,Paolo Saccardo,José Luis Corchero,Elena Garcia-Fruitósspekte der Feldforschung.• Analyse.• Darstellen und Berichten.• Transfer ins Design.• Praxisbeispiele.Die Zielgruppen.Studierende und Dozierende des Designs und anderer Disziplinen, in denen ethnografisch recherchiert wird.Studierende und Dozierende der Kulturanthropologie und -soziologie.Der Autor.Fr978-3-658-21387-9978-3-658-21388-6不公开 发表于 2025-3-28 20:58:00
http://reply.papertrans.cn/47/4679/467853/467853_42.pngoctogenarian 发表于 2025-3-29 02:11:32
http://reply.papertrans.cn/47/4679/467853/467853_43.pngGOAD 发表于 2025-3-29 05:32:10
http://reply.papertrans.cn/47/4679/467853/467853_44.pngGULP 发表于 2025-3-29 10:59:49
A3D 2.0 Update for the Prediction and Optimization of Protein Solubilityine. Finally, we employ defined examples to navigate the A3D RESTful service, a routine to handle extensive protein collections. Altogether, this chapter is conceived to train and assist A3D non-experts in the study of aggregation-prone regions and protein solubility redesign.泄露 发表于 2025-3-29 13:53:17
Cleavable Self-Aggregating Tags (cSAT) for Therapeutic Peptide Expression and Purificationsolution by pH-induced intein self-cleavage. As an example, a yield of about 4.4 μg/mg wet cell pellet was obtained when the cSAT scheme was used for the expression and purification of the therapeutic peptide GLP-1. This strategy provides a viable approach for preparing peptides with authentic N-terfebrile 发表于 2025-3-29 15:52:54
Use Intein Cleavable Polyhydroxyalkanoate Synthase Fusions to Improve Protein SolubilityP) from ., antigen Rv1626 from ., the immunoglobulin G (IgG) binding ZZ domain of protein A derived from ., human tumor necrosis factor alpha (TNFα), human granulocyte colony-stimulating factor (G-CSF), and human interferon alpha 2b (IFNα2b).Trochlea 发表于 2025-3-29 21:12:51
http://reply.papertrans.cn/47/4679/467853/467853_48.pngAMITY 发表于 2025-3-30 03:00:16
http://reply.papertrans.cn/47/4679/467853/467853_49.png种类 发表于 2025-3-30 07:14:30
Soluble Recombinant Protein Production in , TAC125: The Case Study of the Full-Length Human CDKL5 Prion in most of the conventional hosts since the recombinant product accumulates as insoluble aggregates and/or is heavily proteolyzed. As the full-length .CDKL5 production is of great interest both for basic science and as protein drug for an enzyme replacement therapy, its production in the Antarct